Back to search

Article

Elevated plasma levels of CXCL16 in severe COVID-19 patients

2021-09-12

Abstract excerpt

Genome-wide association studies have recently identified 3p21.31, with lead variant pointing to the CXCR6 gene, as the strongest thus far reported susceptibility risk locus for severe manifestation of COVID-19. In order the determine its role, we measured plasma levels of Chemokine (C□X□C motif) ligand 16 (CXCL16) in the plasma of COVID-19 hospitalized patients. CXCL16 interacts with CXCR6 promoting chemotaxis or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b3c3f51-b4a1-5dcb-8b1e-0ab028c09cde
DOI
10.1101/2021.09.07.21263222
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated plasma levels of CXCL16 in severe COVID-19 patientsDOI 10.1101/2021.09.07.21263222
Select a neighboring publication to make it the new centre.